Corteva, Inc. (NYSE:CTVA) Shares Purchased by Savant Capital LLC

Savant Capital LLC lifted its holdings in Corteva, Inc. (NYSE:CTVA) by 6.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 17,995 shares of the company’s stock after buying an additional 1,137 shares during the quarter. Savant Capital LLC’s holdings in Corteva were worth $1,025,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of the business. Hager Investment Management Services LLC acquired a new position in Corteva during the 4th quarter valued at approximately $27,000. Golden State Wealth Management LLC acquired a new stake in Corteva in the fourth quarter worth $32,000. Capital Advisors Ltd. LLC lifted its stake in Corteva by 44.4% in the third quarter. Capital Advisors Ltd. LLC now owns 566 shares of the company’s stock valued at $33,000 after buying an additional 174 shares during the last quarter. First Financial Corp IN acquired a new position in shares of Corteva during the fourth quarter valued at $35,000. Finally, Albion Financial Group UT grew its position in shares of Corteva by 112.6% during the fourth quarter. Albion Financial Group UT now owns 606 shares of the company’s stock worth $35,000 after acquiring an additional 321 shares during the last quarter. Institutional investors own 81.54% of the company’s stock.

Corteva Stock Performance

Shares of CTVA opened at $64.00 on Friday. The company has a 50-day moving average of $60.30 and a two-hundred day moving average of $58.41. The stock has a market cap of $43.99 billion, a price-to-earnings ratio of 49.61, a PEG ratio of 1.85 and a beta of 0.78. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.45 and a quick ratio of 0.96. Corteva, Inc. has a one year low of $50.01 and a one year high of $66.24.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.32 earnings per share for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. On average, equities research analysts expect that Corteva, Inc. will post 2.83 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Monday, March 3rd will be given a dividend of $0.17 per share. The ex-dividend date is Monday, March 3rd. This represents a $0.68 dividend on an annualized basis and a yield of 1.06%. Corteva’s payout ratio is presently 52.71%.

Corteva announced that its board has initiated a share repurchase program on Tuesday, November 19th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the company to repurchase up to 7.5% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s board of directors believes its shares are undervalued.

Analyst Ratings Changes

CTVA has been the subject of several analyst reports. Wells Fargo & Company boosted their price objective on Corteva from $67.00 to $73.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 28th. UBS Group lowered their price target on Corteva from $74.00 to $73.00 and set a “buy” rating on the stock in a report on Friday, January 10th. Citigroup upped their price objective on shares of Corteva from $69.00 to $74.00 and gave the stock a “buy” rating in a report on Wednesday, January 29th. KeyCorp raised their target price on shares of Corteva from $68.00 to $70.00 and gave the company an “overweight” rating in a research note on Friday, February 7th. Finally, Oppenheimer upped their price target on shares of Corteva from $70.00 to $72.00 and gave the stock an “outperform” rating in a research note on Friday, February 7th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Corteva presently has an average rating of “Moderate Buy” and a consensus target price of $67.73.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.